Friday, April 9, 2021

April 09, 2021 at 10:51PM CPG Sec. 130.300 FDA Access to Results of Quality Assurance Program Audits and Inspections

ORA and CDER agree to replace and/or withdraw CPGs in favor of using guidance or procedural documents, as appropriate per GGP regulations.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2YLit9p

No comments:

Post a Comment